Haenraets Karen, Foster Edmund, Johannssen Helge, Kandra Vinnie, Frezel Noémie, Steffen Timothy, Jaramillo Valeria, Paterna Jean-Charles, Zeilhofer Hanns Ulrich, Wildner Hendrik
Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Institute of Pharmaceutical Sciences, Swiss Federal Institute (ETH) Zurich, Zurich, Switzerland.
J Neurochem. 2017 Sep;142(5):721-733. doi: 10.1111/jnc.14124. Epub 2017 Aug 4.
Recombinant adeno-associated virus (rAAV) vector-mediated gene transfer into genetically defined neuron subtypes has become a powerful tool to study the neuroanatomy of neuronal circuits in the brain and to unravel their functions. More recently, this methodology has also become popular for the analysis of spinal cord circuits. To date, a variety of naturally occurring AAV serotypes and genetically modified capsid variants are available but transduction efficiency in spinal neurons, target selectivity, and the ability for retrograde tracing are only incompletely characterized. Here, we have compared the transduction efficiency of seven commonly used AAV serotypes after intraspinal injection. We specifically analyzed local transduction of different types of dorsal horn neurons, and retrograde transduction of dorsal root ganglia (DRG) neurons and of neurons in the rostral ventromedial medulla (RVM) and the somatosensory cortex (S1). Our results show that most of the tested rAAV vectors have similar transduction efficiency in spinal neurons. All serotypes analyzed were also able to transduce DRG neurons and descending RVM and S1 neurons via their spinal axon terminals. When comparing the commonly used rAAV serotypes to the recently developed serotype 2 capsid variant rAAV2retro, a > 20-fold increase in transduction efficiency of descending supraspinal neurons was observed. Conversely, transgene expression in retrogradely transduced neurons was strongly reduced when the human synapsin 1 (hSyn1) promoter was used instead of the strong ubiquitous hybrid cytomegalovirus enhancer/chicken β-actin promoter (CAG) or cytomegalovirus (CMV) promoter fragments. We conclude that the use of AAV2retro greatly increases transduction of neurons connected to the spinal cord via their axon terminals, while the hSyn1 promoter can be used to minimize transgene expression in retrogradely connected neurons of the DRG or brainstem. Cover Image for this issue: doi. 10.1111/jnc.13813.
重组腺相关病毒(rAAV)载体介导的基因转移到基因定义的神经元亚型中,已成为研究大脑中神经回路的神经解剖学及其功能的有力工具。最近,这种方法在脊髓回路分析中也变得很流行。迄今为止,有多种天然存在的AAV血清型和基因改造的衣壳变体可供使用,但脊髓神经元中的转导效率、靶标选择性和逆行追踪能力仅得到不完全的表征。在这里,我们比较了脊髓内注射后七种常用AAV血清型的转导效率。我们特别分析了不同类型背角神经元的局部转导,以及背根神经节(DRG)神经元、延髓头端腹内侧(RVM)和体感皮层(S1)神经元的逆行转导。我们的结果表明,大多数测试的rAAV载体在脊髓神经元中具有相似的转导效率。所有分析的血清型也能够通过其脊髓轴突终末转导DRG神经元以及下行的RVM和S1神经元。当将常用的rAAV血清型与最近开发的血清型2衣壳变体rAAV2retro进行比较时,观察到下行脊髓上神经元的转导效率增加了20倍以上。相反,当使用人突触素1(hSyn1)启动子代替强泛在性杂交巨细胞病毒增强子/鸡β-肌动蛋白启动子(CAG)或巨细胞病毒(CMV)启动子片段时,逆行转导神经元中的转基因表达会大大降低。我们得出结论,使用AAV2retro可大大增加通过其轴突终末与脊髓相连的神经元的转导,而hSyn1启动子可用于使DRG或脑干逆行连接神经元中的转基因表达最小化。本期封面图片:doi. 10.1111/jnc.13813。